Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
Also Known As
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies1000
Dilyx Biotechnologies
Dilyx Biotechnologies provides protein solubility analysis kits to help scientists with life-science research.
Sector
Subsector
Location
Protagen Protein Services
Protagen is a German company specializing in protein analytics and research.
Sector
Subsector
Keywords
Location
Applied Protein Biotechnologies
Developer of recombinant proteins and products for protein biology research
Sector
Subsector
Location
Advanced Protein Technology
Recombinant proteins for research
Sector
Subsector
Location
M&A Details1
Transaction name
Acquired by
Bio-Techne
announced date
price
Financials
Funding Rounds6
Number of Funding Rounds
Money Raised
Their latest funding was raised on 14.10.2010. Their latest investor Novo Holdings. Their latest round Series F
Essex Woodlands Healthcare Partners
Essex Woodlands is a leading healthcare venture capital firm.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Novo Holdings
Novo Holdings is a life science investor focused on growing investment assets for scientific, social, and humanitarian purposes.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Co-Investors
Investors9
Number of lead investors
Number of investors
Novo Holdings
Novo Holdings is a life science investor focused on growing investment assets for scientific, social, and humanitarian purposes.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Jack Nielsen
Jack Nielsen, Partner, joined Novo A/S in 2001 and is located in San Francisco, CA. From 1990 to 2001 Mr. Nielsen held various positions in the Novo Nordisk business area which in 2000 became Novozymes A/S. Before joining Novo Ventures, Mr. Nielsen was for four years deeply involved in designing the R&D strategy for Novozymes’ activities in the cereal food area, resulting in the development and launch of novel recombinant lipase and amylase enzymes. Jack has furthermore been involved in collaborations with Procter & Gamble, Danisco, and Quest International to identify new enzymes for the detergent and cereal food industry. Prior hereto, he held positions in marketing and technical services in the textile and personal care area, and started his career in the field of large-scale manufacturing of enzymes. Mr. Nielsen serves on the board of directors of Cell Biosciences, Inc., MediQuest Therapeutics, Inc., Protein Forest, Inc., Reata Pharmaceuticals, Inc. and NeoMend, Inc., and he is a former director of Panacos Pharmaceuticals, Inc., Nuevolution A/S, and CardioOptics, Inc. Jack Nielsen obtained his MSc in 1990 from the Technical University of Denmark, and his Master in Management of Technology from the Center for Technology, Economics and Management in Copenhagen in 2000.
current job
RBC Venture Partners
RBC Capital Markets is a trusted and innovative partner in capital markets, banking and finance.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Wellcome Trust
Wellcome is a global charitable foundation supporting science to improve health.
Sector
Subsector
Location
total rounds
total raised
count Of Investments
count Of Exists
Acquisitions4
Brightwell Technology acquired by ProteinSimple
acquirer
date
type
Brightwell Technology
Brightwell develops image-based particle analysis technology for pharmaceutical, life sciences, and industrial sectors.
Sector
Subsector
Keywords
Location
Convergent Bioscience acquired by ProteinSimple
acquirer
date
type
Convergent Bioscience
Convergent Bioscience manufactures analytical instruments and reagent kits for protein analysis.
Sector
Subsector
Keywords
Location
Protein Forest acquired by ProteinSimple
acquirer
date
type
Protein Forest
Pigment Forest, Inc. develops and sells instruments, consumables and software for protein separation and bioanalysis applications.
Sector
Subsector
Keywords
Location
total rounds
total raised
People
Founders1
Nancy Allbritton
Nancy Allbritton is a Professor of Bioengineering at University of Washington. He Attended Massachusetts Institute of Technology.
current job
organization founded
Nancy Allbritton
Employee Profiles76
Tufan Aydogdu
Field applications manager, biologics business unit partner
Christopher Heger
Senior manager, applications science